Business
DDReg Pharma Wins Entrepreneur of the Year in Service Business Award for 2026
By News Desk ·
Key takeaways
- DDReg Pharma won the Entrepreneur India Award for Entrepreneur of the Year in Service Business in 2026.
- Founded in 2009 by Neeraj Pant and Neeti Pant, DDReg has enabled over 2,000 global regulatory submissions.
- DDReg offers regulatory affairs, pharmacovigilance and clinical regulatory services across pharmaceuticals, biologics and medical devices.
DDReg Pharma has won the Entrepreneur India Award for Entrepreneur of the Year in Service Business in 2026, the company said in a PRLog announcement. The award recognizes business achievement and innovation across industries, according to the announcement. DDReg is a life sciences consulting company that provides regulatory affairs, pharmacovigilance and clinical regulatory services to pharmaceutical, biotechnology and medical device organizations.
DDReg's 2026 Entrepreneur India Award
The company said the recognition highlights the role of specialized professional services in helping global life sciences companies navigate complex, evolving regulatory frameworks. DDReg was founded in 2009 by Neeraj Pant and Neeti Pant and has grown from a local regulatory consultancy in India into a global life sciences partner, according to the announcement. The firm has enabled over 2,000 global regulatory submissions across pharmaceuticals, biologics and medical devices.
The award follows two honors at the ET Health Conclave last year: Excellence in Pharmaceutical Consulting & Compliance and Top Emerging Company in Life Sciences Services. Neeraj Pant, co-founder and director, has represented the company on industry panels alongside clinical experts to discuss genomics and personalized medicine, the company said.
DDReg organizes its work around three service areas. Regulatory affairs services guide innovative and generic molecules from concept to global commercialization. Pharmacovigilance services manage drug safety operations and data submissions across global markets. Clinical regulatory services provide strategic clinical trial submission pathways intended to reduce time-to-market. The company said it combines scientific depth with RegTech innovation, including AI-driven regulatory intelligence platforms.
"The Entrepreneur India Awards 2026 recognition marks a vital chapter in our development," the company said in the announcement.
DDReg's Service Lines and Digital Tools
DDReg describes itself on its company website as a global life sciences consulting company specializing in regulatory affairs, pharmacovigilance and clinical research services. The company says it supports pharmaceutical, biotechnology and medical device organizations across the product lifecycle to accelerate safe market access globally. Its stated approach combines industry experience with digital transformation.
Companies in this story
- DDReg Pharma · www.ddregpharma.com